Alessandra Campbell Pinheiro and Marcus Vinícius Nora de Souza

RSC Med. Chem., 2022, 13, 1029
DOI: 10.1039/D1MD00362C

Exploring oxidovanadium(iv) homoleptic complexes with 8-hydroxyquinoline derivatives as prospective antitrypanosomal agents

Gonzalo Scalese, Ignacio Machado, Isabel Correia, Joao Costa Pessoa, Lucía Bilbao, Leticia Pérez-Diaz and Dinorah Gambino

New J. Chem., 2019, 43, 17756
DOI: 10.1039/C9NJ02589H

Glycosylated metal chelators as anti-parasitic agents with tunable selectivity

Andrew Reddy, Leandro Stefano Sangenito, Arthur de Azevedo Guedes, Marta Helena Branquinha, Kevin Kavanagh, John McGinley, André Luis Souza dos Santos and Trinidad Velasco-Torrijos

Dalton Trans., 2017, 46, 5297
DOI: 10.1039/C6DT04615K

N,C-Coupled naphthylisoquinoline alkaloids: a versatile new class of axially chiral natural products

Nasir Tajuddeen and Gerhard Bringmann

Nat. Prod. Rep., 2021, 38, 2154
DOI: 10.1039/D1NP00020A

Antitubercular evaluation of dihydropyridine–triazole conjugates: design, synthesis, in vitro screening, SAR and in silico ADME predictions

Ajay Kishor Kushawaha, Arvind Kumar Jaiswal, Jay Gupta, Sarita Katiyar, Alisha Ansari, Hemlata Bhatt, Sandeep K. Sharma, Abhijit Deb Choudhury, Rabi Sankar Bhatta, Bhupendra N. Singh and Koneni V. Sashidhara

RSC Med. Chem., 2024, 15, 2867
DOI: 10.1039/D4MD00377B

Collaborative virtual screening to elaborate an imidazo[1,2-a]pyridine hit series for visceral leishmaniasis

Yuichiro Akao, Stacie Canan, Yafeng Cao, Kevin Condroski, Ola Engkvist, Sachiko Itono, Rina Kaki, Chiaki Kimura, Thierry Kogej, Kazuya Nagaoka, Akira Naito, Hiromi Nakai, Garry Pairaudeau, Constantin Radu, Ieuan Roberts, Mitsuyuki Shimada, David Shum, Nao-aki Watanabe, Huanxu Xie, Shuji Yonezawa, Osamu Yoshida, Ryu Yoshida, Charles Mowbray and Benjamin Perry

RSC Med. Chem., 2021, 12, 384
DOI: 10.1039/D0MD00353K

Simple accessible clemastine fumarate analogues as effective antileishmanials

Rebecca L. Charlton, Douglas O. Escrivani, Christopher Brown, Niranjan Thota, Victor S. Agostino, Exequiel O. J. Porta, Timur Avkiran, Andrew T. Merritt, Paul W. Denny, Bartira Rossi-Bergmann and Patrick G. Steel

RSC Med. Chem., 2025, 16, 1686
DOI: 10.1039/D4MD01004C

A hyaluronic acid–pentamidine bioconjugate as a macrophage mediated drug targeting delivery system for the treatment of leishmaniasis

N. Micale, A. Piperno, N. Mahfoudh, U. Schurigt, M. Schultheis, P. G. Mineo, T. Schirmeister, A. Scala and G. Grassi

RSC Adv., 2015, 5, 95545
DOI: 10.1039/C5RA18019H

Synthesis, characterization and evaluation of lecithin-based nanocarriers for the enhanced pharmacological and oral pharmacokinetic profile of amphotericin B

Ibrahim Javed, Syed Zajif Hussain, Irfan Ullah, Imran Khan, Muhammad Ateeq, Gul Shahnaz, Habib ur Rehman, Muhammad Tahir Razi, Muhammad Raza Shah and Irshad Hussain

J. Mater. Chem. B, 2015, 3, 8359
DOI: 10.1039/C5TB01258A

Targeting of the Leishmania mexicana cysteine protease CPB2.8ΔCTE by decorated fused benzo[b]thiophene scaffold

A. Scala, N. Micale, A. Piperno, A. Rescifina, T. Schirmeister, J. Kesselring and G. Grassi

RSC Adv., 2016, 6, 30628
DOI: 10.1039/C6RA05557E

Effect of functionalities on the crystal structures of new zinc(ii) dithiocarbamates: a combined anti-leishmanial and thermal decomposition study

Krishna K. Manar, Chote L. Yadav, Neeraj Tiwari, Rakesh K. Singh, Akhilesh Kumar, Michael G. B. Drew and Nanhai Singh

CrystEngComm, 2017, 19, 2660
DOI: 10.1039/C7CE00211D

Computational study of quinoline-based thiadiazole compounds as potential antileishmanial inhibitors

Ayoub Khaldan, Soukaina Bouamrane, Reda El-mernissi, Marwa Alaqarbeh, Halima Hajji, Nada Alsakhen, Hamid Maghat, Mohammed Aziz Ajana, Abdelouahid Sbai, Mohammed Bouachrine and Tahar Lakhlifi

New J. Chem., 2022, 46, 17554
DOI: 10.1039/D2NJ03253H

Anti-leishmanial study of discrete tetrahedral zinc(ii) β-oxodithioester complexes

Chote Lal Yadav, Anamika, Rajan Singh, Akhilesh Kumar, Rakesh K. Singh, Michael G. B. Drew, Krishna K. Manar and Nanhai Singh

New J. Chem., 2025, 49, 484
DOI: 10.1039/D4NJ04275A

Synthesis, SAR and biological studies of sugar amino acid-based almiramide analogues: N-methylation leads the way

Dipendu Das, Hina P. A. Khan, Rahul Shivahare, Suman Gupta, Jayanta Sarkar, Mohd. Imran Siddiqui, Ravi Sankar Ampapathi and Tushar Kanti Chakraborty

Org. Biomol. Chem., 2017, 15, 3337
DOI: 10.1039/C6OB02610A

Identification of Selective Inhibitors of LdDHFR Enzyme Using Pharmacoinformatic Methods

Vishnu Kumar Sharma and Prasad V. Bharatam

Journal of Computational Biology, 2021, 28, 43
DOI: 10.1089/cmb.2019.0332

Expeditious synthesis, antileishmanial and antioxidant activities of novel 3-substituted-4-hydroxycoumarin derivatives

Zahid Zaheer, Firoz A. Kalam Khan, Jaiprakash N. Sangshetti and Rajendra H. Patil

Chinese Chemical Letters, 2016, 27, 287
DOI: 10.1016/j.cclet.2015.10.028

Small Molecule–Peptide Conjugates as Dimerization Inhibitors of Leishmania infantum Trypanothione Disulfide Reductase

Alejandro Revuelto, Isabel López-Martín, Héctor de Lucio, Juan Carlos García-Soriano, Nicola Zanda, Sonia de Castro, Federico Gago, Antonio Jiménez-Ruiz, Sonsoles Velázquez and María-José Camarasa

Pharmaceuticals, 2021, 14, 689
DOI: 10.3390/ph14070689

Targeting peptide based therapeutics: Integrated computational and experimental studies of autophagic regulation in host‐parasite interaction

Vrushali Guhe and Shailza Singh

ChemMedChem, 2024, 19
DOI: 10.1002/cmdc.202300679

Recent Advances in Polymeric Nanoparticle-Encapsulated Drugs against Intracellular Infections

Arturo Sánchez, Susana P. Mejía and Jahir Orozco

Molecules, 2020, 25, 3760
DOI: 10.3390/molecules25163760

Synthesis of quercetin based self-assembling supramolecular amphiphiles for amphotericin B delivery

Jawad ur Rehman, Imdad Ali, Salim Saifullah, Shafi Ullah, Muhammad Imran and Muhammad Raza Shah

Journal of Molecular Liquids, 2021, 333, 115941
DOI: 10.1016/j.molliq.2021.115941

1,4-Disubstituted-1,2,3-Triazole Compounds Induce Ultrastructural Alterations in Leishmania amazonensis Promastigote: An in Vitro Antileishmanial and in Silico Pharmacokinetic Study

Fernando Almeida-Souza, Verônica Diniz da Silva, Gabriel Xavier Silva, Noemi Nosomi Taniwaki, Daiana de Jesus Hardoim, Camilla Djenne Buarque, Ana Lucia Abreu-Silva and Kátia da Silva Calabrese

IJMS, 2020, 21, 6839
DOI: 10.3390/ijms21186839

Infectivity and Drug Susceptibility Profiling of Different Leishmania-Host Cell Combinations

Kyung-Hwa Baek, Laura Piel, Thibault Rosazza, Eric Prina, Gerald F. Späth and Joo Hwan No

Pathogens, 2020, 9, 393
DOI: 10.3390/pathogens9050393

Leishmaniasis: where are we and where are we heading?

Santanu Sasidharan and Prakash Saudagar

Parasitol Res, 2021, 120, 1541
DOI: 10.1007/s00436-021-07139-2

Recent Advances in Chemotherapeutics for Leishmaniasis: Importance of the Cellular Biochemistry of the Parasite and Its Molecular Interaction with the Host

Ranjeet Singh, Mohammad Kashif, Prateek Srivastava and Partha Pratim Manna

Pathogens, 2023, 12, 706
DOI: 10.3390/pathogens12050706

Novel chemical scaffold as potential drug against Leishmania donovani: Integrated computational and experimental approaches

Preeti Ranjan and Vikash Kumar Dubey

J of Cellular Biochemistry, 2023, 124, 1404
DOI: 10.1002/jcb.30455

Pyrrolopyrimidine vs Imidazole-Phenyl-Thiazole Scaffolds in Nonpeptidic Dimerization Inhibitors of Leishmania infantum Trypanothione Reductase

Alejandro Revuelto, Marta Ruiz-Santaquiteria, Héctor de Lucio, Ana Gamo, Alejandra A. Carriles, Kilian Jesús Gutiérrez, Pedro A. Sánchez-Murcia, Juan A. Hermoso, Federico Gago, María-José Camarasa, Antonio Jiménez-Ruiz and Sonsoles Velázquez

ACS Infect. Dis., 2019, 5, 873
DOI: 10.1021/acsinfecdis.8b00355

Antileishmanial Drug Discovery and Development: Time to Reset the Model?

Ana Isabel Olías-Molero, Concepción de la Fuente, Montserrat Cuquerella, Juan J. Torrado and José M. Alunda

Microorganisms, 2021, 9, 2500
DOI: 10.3390/microorganisms9122500

Emerging impact of triazoles as anti-tubercular agent

Anindra Sharma, Anand K. Agrahari, Sanchayita Rajkhowa and Vinod K. Tiwari

European Journal of Medicinal Chemistry, 2022, 238, 114454
DOI: 10.1016/j.ejmech.2022.114454

Photodynamic evaluation of triazine appended porphyrins as anti-leishmanial and anti-tumor agents

Monisha Manathanath, Santanu Sasidharan, Prakash Saudagar, Unnikrishnan Gopalakrishna Panicker and Subramaniam Sujatha

Polyhedron, 2022, 217, 115711
DOI: 10.1016/j.poly.2022.115711

Recent Applications of the Multicomponent Synthesis for Bioactive Pyrazole Derivatives

Diana Becerra, Rodrigo Abonia and Juan-Carlos Castillo

Molecules, 2022, 27, 4723
DOI: 10.3390/molecules27154723

Direct C–N coupling of azoles with ethers via oxidative C–H activation under metal–organic framework catalysis

Khoa D. Nguyen, Son H. Doan, Anh N.V. Ngo, Tung T. Nguyen and Nam T.S. Phan

Journal of Industrial and Engineering Chemistry, 2016, 44, 136
DOI: 10.1016/j.jiec.2016.08.025

The chemotherapeutic potential of chalcones against leishmaniases: a review

Nasir Tajuddeen, Murtala Bindawa Isah, Mukhtar Adeiza Suleiman, Fanie R. van Heerden and Mohammed Auwal Ibrahim

International Journal of Antimicrobial Agents, 2018, 51, 311
DOI: 10.1016/j.ijantimicag.2017.06.010

Pharmaceutical Prospects of Bee Products: Special Focus on Anticancer, Antibacterial, Antiviral, and Antiparasitic Properties

Firzan Nainu, Ayu Masyita, Muh. Akbar Bahar, Muhammad Raihan, Shajuthi Rahman Prova, Saikat Mitra, Talha Bin Emran and Jesus Simal-Gandara

Antibiotics, 2021, 10, 822
DOI: 10.3390/antibiotics10070822

Validation of Putative Apicoplast-Targeting Drugs Using a Chemical Supplementation Assay in Cultured Human Malaria Parasites

Taher Uddin, Geoffrey Ian McFadden and Christopher Dean Goodman

Antimicrob Agents Chemother, 2018, 62
DOI: 10.1128/AAC.01161-17

Phenotype Screening of an Azole-bisindole Chemical Library Identifies URB1483 as a New Antileishmanial Agent Devoid of Toxicity on Human Cells

Aurora Diotallevi, Laura Scalvini, Gloria Buffi, Yolanda Pérez-Pertejo, Mauro De Santi, Michele Verboni, Gianfranco Favi, Mauro Magnani, Alessio Lodola, Simone Lucarini and Luca Galluzzi

ACS Omega, 2021, 6, 35699
DOI: 10.1021/acsomega.1c05611

An eco‐friendly, sustainable, and greener approach to the synthesis of Dihydroquinazolin‐4(1H)‐ones using a deep eutectic solvent

Gobind Kumar, Pule Seboletswe, Neha Manhas, Parvesh Singh, Gaurav Bhargava, Jaspreet Kaur Rajput and Rupesh Kumar

Journal of Heterocyclic Chem, 2024, 61, 347
DOI: 10.1002/jhet.4764

Evaluation of curcumin and CM11 peptide alone and in combination against amastigote form of Iranian strain of L. major (MRHO/IR75/ER) in vitro

G. Aqeele, P. Shayan, E. Ebrahimzade Abkooh and M. Mohebali

Experimental Parasitology, 2021, 229, 108151
DOI: 10.1016/j.exppara.2021.108151

Antiparasitic activities of novel pyrimidine N‐acylhydrazone hybrids

Julia Poletto, Michael J. V. da Silva, Andrey P. Jacomini, Danielle L. Bidóia, Hélito Volpato, Celso Vataru Nakamura and Fernanda A. Rosa

Drug Development Research, 2021, 82, 230
DOI: 10.1002/ddr.21745

Identification of potential antileishmanial agents via structure-based molecular simulations

Nima Razzaghi-Asl and Niloufar Hashemi

Journal of Molecular Graphics and Modelling, 2022, 110, 108039
DOI: 10.1016/j.jmgm.2021.108039

Assessing different thiazolidine and thiazole based compounds as antileishmanial scaffolds

Ermin Schadich, Anna Kryshchyshyn-Dylevych, Serhiy Holota, Pavel Polishchuk, Petr Džubak, Sona Gurska, Marian Hajduch and Roman Lesyk

Bioorganic & Medicinal Chemistry Letters, 2020, 30, 127616
DOI: 10.1016/j.bmcl.2020.127616

Synthesis, Leishmanicidal, Trypanocidal, Antiproliferative Assay and Apoptotic Induction of (2-Phenoxypyridin-3-yl)naphthalene-1(2H)-one Derivatives

Zuleima Blanco, Esteban Fernandez-Moreira, Michael R. Mijares, Carmen Celis, Gricelis Martínez, Juan B. De Sanctis, Soňa Gurská, Petr Džubák, Marián Hajdůch, Ali Mijoba, Yael García, Xenón Serrano, Nahum Herrera, Jhonny Correa-Abril, Yonathan Parra, Jorge Ángel, Hegira Ramírez and Jaime E. Charris

Molecules, 2022, 27, 5626
DOI: 10.3390/molecules27175626

In Vitro and In Silico Assessment of Antileishmanial Potential of Novel Tri‐ and Penta‐Valent Antimony Complexes With Phenolic Ligands

Syeda Aaliya Shehzadi, Faiz Ahmed, Arshad Islam, Zeshan Ahmed, Khizar Abdullah, Farhan Younas, Ali Haider, Muhammad Tariq, Ahmed Noureldeen, Bander Albogami, Hadeer Darwish and Fatemah Enad M. Alajmi

Drug Development Research, 2025, 86
DOI: 10.1002/ddr.70067

Evaluation of the inhibitory potential of Valproic acid against histone deacetylase ofLeishmania donovaniand computational studies of Valproic acid derivatives

Pragya Prasanna, Tanuja Joshi, Manish Pant, Hemlata Pundir and Subhash Chandra

Journal of Biomolecular Structure and Dynamics, 2023, 41, 5447
DOI: 10.1080/07391102.2022.2087103

Synthesis, anti-leishmanial screening, molecular docking, and ADME study of 1-amidoalkyl 2-naphthol derivatives catalyzed by amino acid ionic liquid

Nitin R. Rode, Aafaq A. Tantray, Amruta V. Shelar, Rajendra H. Patil and Santosh S. Terdale

Res Chem Intermed, 2022, 48, 2391
DOI: 10.1007/s11164-022-04723-8

Synthesis of some novel 4-amino-4H-1,2,4-triazole-3-thiol derivatives

Mai M. Khalaf, Hany M. Abd El-Lateef, Amer Anwar Amer and Amr Hassan Moustafa

J IRAN CHEM SOC, 2024, 21, 1291
DOI: 10.1007/s13738-024-02997-w

30th Annual GP2A Medicinal Chemistry Conference

Niamh M. O’Boyle, Jean-Jacques Helesbeux, Mary J. Meegan, Astrid Sasse, Elizabeth O’Shaughnessy, Alina Qaisar, Aoife Clancy, Florence McCarthy and Pascal Marchand

Pharmaceuticals, 2023, 16, 432
DOI: 10.3390/ph16030432

An integrative approach using systems biology, mutational analysis with molecular dynamics simulation to challenge the functionality of a target protein

Nikita Bora and Anupam Nath Jha

Chem Biol Drug Des, 2019, 93, 1050
DOI: 10.1111/cbdd.13502

Synthesis, protease inhibition, and antileishmanial activity of new benzoxazoles derived from acetophenone or benzophenone and synthetic precursors

Laís R. S. Folquitto, Priscila F. Nogueira, Patrícia F. Espuri, Vanessa S. Gontijo, Thiago B. de Souza, Marcos J. Marques, Diogo T. Carvalho, Wagner A. S. Júdice and Danielle F. Dias

Med Chem Res, 2017, 26, 1149
DOI: 10.1007/s00044-017-1824-y

Molecular docking, network pharmacology, and QSAR modelling studies of benzo[c]phenanthridines – novel antileishmaniasis agents

David Kikaawa and E. Vadivel

Journal of Biomolecular Structure and Dynamics, 2025, 43, 2674
DOI: 10.1080/07391102.2024.2417226

Synthesis and antileishmanial evaluation of thiazole orange analogs

Ahmed Abdelhameed, Xiaoping Liao, Craig A. McElroy, April C. Joice, Liva Rakotondraibe, Junan Li, Carla Slebodnick, Pu Guo, W. David Wilson and Karl A. Werbovetz

Bioorganic & Medicinal Chemistry Letters, 2020, 30, 126725
DOI: 10.1016/j.bmcl.2019.126725

Chemometric modeling, inverse docking, and molecular simulations-driven design for multilayered prioritization of novel leishmanicidal agents based on a 2-aminobenzimidazole scaffold

Arpita Biswas, Arnab Bhattacharjee, Supratik Kar and Probir Kumar Ojha

Mol Divers, 2025
DOI: 10.1007/s11030-025-11228-0

Discovery of benzimidazole‐based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis

Laura De Luca, Stefania Ferro, Maria Rosa Buemi, Anna‐Maria Monforte, Rosaria Gitto, Tanja Schirmeister, Louis Maes, Antonio Rescifina and Nicola Micale

Chem Biol Drug Des, 2018, 92, 1585
DOI: 10.1111/cbdd.13326

Synthesis and In Vitro Anti Leishmania amazonensis Biological Screening of Morita-Baylis-Hillman Adducts Prepared from Eugenol, Thymol and Carvacrol

Francisco Xavier, Klinger Rodrigues, Ramon De Oliveira, Claudio Lima Junior, Juliana Rocha, Tatjana Keesen, Marcia De Oliveira, Fábio Silva and Mário Vasconcellos

Molecules, 2016, 21, 1483
DOI: 10.3390/molecules21111483

Structure modifications of 2-phenylquinoline by Aspergillus genera produce novel derivatives with potent leishmanicidal and anti-inflammatory properties

Keylla Lençone Mischiatti, Ida Chapaval Pimentel, Lucélia Donatti, José Dias de Souza Filho, Mariana Vieira Porsani, Brás Heleno de Oliveira and Almeriane Maria Weffort-Santos

Journal of Molecular Structure, 2022, 1268, 133665
DOI: 10.1016/j.molstruc.2022.133665

The Potential Use of Peptides in the Fight against Chagas Disease and Leishmaniasis

Hayelom Berhe, Mahesh Kumar Cinthakunta Sridhar, Mulate Zerihun and Nir Qvit

Pharmaceutics, 2024, 16, 227
DOI: 10.3390/pharmaceutics16020227

Development of novel dual-target drugs against visceral leishmaniasis and combinational study with miltefosine

Kushal Bora, Manash Sarma, Shankar Prasad Kanaujia and Vikash Kumar Dubey

Free Radical Biology and Medicine, 2024, 225, 275
DOI: 10.1016/j.freeradbiomed.2024.10.257

Peptides to Tackle Leishmaniasis: Current Status and Future Directions

Alberto A. Robles-Loaiza, Edgar A. Pinos-Tamayo, Bruno Mendes, Cátia Teixeira, Cláudia Alves, Paula Gomes and José R. Almeida

IJMS, 2021, 22, 4400
DOI: 10.3390/ijms22094400

A Core‐Linker‐Polyamine (CLP) Strategy Enables Rapid Discovery of Antileishmanial Aminoalkylquinolinecarboxamides That Target Oxidative Stress Mechanism

Archana P. Shah, Neha Hura, Neerupudi Kishore Babu, Nibedita Roy, Vajja Krishna Rao, Anindita Paul, Pradyot Kumar Roy, Sushma Singh and Sankar K. Guchhait

ChemMedChem, 2022, 17
DOI: 10.1002/cmdc.202200109

Krebs cycle enzymes for targeted therapeutics and immunotherapy for anti-leishmanial drug development using: Pathways, potential targets, and future perspectives

Preeti Ranjan and Vikash Kumar Dubey

Life Sciences, 2023, 322, 121314
DOI: 10.1016/j.lfs.2022.121314

Need for sustainable approaches in antileishmanial drug discovery

Sarah Hendrickx, G. Caljon and L. Maes

Parasitol Res, 2019, 118, 2743
DOI: 10.1007/s00436-019-06443-2

Synthesis of Novel Quaternary Ammonium Salts and Their in Vitro Antileishmanial Activity and U-937 Cell Cytotoxicity

Sandra Duque-Benítez, Luz Ríos-Vásquez, Rogelio Ocampo-Cardona, David Cedeño, Marjorie Jones, Iván Vélez and Sara Robledo

Molecules, 2016, 21, 381
DOI: 10.3390/molecules21040381

Preliminary investigation of novel tetra-tailed macrocycle amphiphile based nano-vesicles for amphotericin B improved oral pharmacokinetics

Imdad Ali, Jawad ur Rehman, Shafi Ullah, Muhammad Imran, Ibrahim Javed, Babiker M. El-Haj, Heyam Saad Ali, Muhammad Arfan and Muhammad Raza Shah

Artificial Cells, Nanomedicine, and Biotechnology, 2018, 46, 1204
DOI: 10.1080/21691401.2018.1536061

Antileishmanial Activity of Pyrazolopyridine Derivatives and Their Potential as an Adjunct Therapy with Miltefosine

Devireddy Anand, Pawan Kumar Yadav, Om P. S. Patel, Naveen Parmar, Rahul K. Maurya, Preeti Vishwakarma, Kanumuri S. R. Raju, Isha Taneja, M. Wahajuddin, Susanta Kar and Prem P. Yadav

J. Med. Chem., 2017, 60, 1041
DOI: 10.1021/acs.jmedchem.6b01447

A recent update on new synthetic chiral compounds with antileishmanial activity

Michele Verboni, Diego Olivieri and Simone Lucarini

Chirality, 2022, 34, 1279
DOI: 10.1002/chir.23494

Inspection of in-house designed novel thiochromone amino-acid conjugate derivatives as Lm-NMT inhibitor – An in-silico analysis

Samridhi Johri, Banoth Karan Kumar, Sanchita Dey, Faheem, Rafael Balana-Fouce, Kondapalli Venkata Gowri Chandra Sekhar, Selvaraj Kunjiappan and Sankaranarayanan Murugesan

Journal of Molecular Graphics and Modelling, 2023, 119, 108397
DOI: 10.1016/j.jmgm.2022.108397

Leishmania treatment and prevention: Natural and synthesized drugs

Adnan A. Bekhit, Eman El-Agroudy, Aliaa Helmy, Tamer M. Ibrahim, Amin Shavandi and Alaa El-Din A. Bekhit

European Journal of Medicinal Chemistry, 2018, 160, 229
DOI: 10.1016/j.ejmech.2018.10.022

Novel Aminoquinoline Derivatives Significantly Reduce Parasite Load in Leishmania infantum Infected Mice

Jelena Konstantinović, Milica Videnović, Stefania Orsini, Katarina Bogojević, Sarah D’Alessandro, Diletta Scaccabarozzi, Nataša Terzić Jovanović, Luigi Gradoni, Nicoletta Basilico and Bogdan A. Šolaja

ACS Med. Chem. Lett., 2018, 9, 629
DOI: 10.1021/acsmedchemlett.8b00053

Ultrasonic treatment of CoFe2O4@B2O3-SiO2 as a new hybrid magnetic composite nanostructure and catalytic application in the synthesis of dihydroquinazolinones

Ali Maleki, Morteza Aghaei, Hamid Reza Hafizi-Atabak and Mohammad Ferdowsi

Ultrasonics Sonochemistry, 2017, 37, 260
DOI: 10.1016/j.ultsonch.2017.01.022

Antileishmanial Chemotherapy through Clemastine Fumarate Mediated Inhibition of the Leishmania Inositol Phosphorylceramide Synthase

John G. M. Mina, Rebecca L. Charlton, Edubiel Alpizar-Sosa, Douglas O. Escrivani, Christopher Brown, Amjed Alqaisi, Maria Paula G. Borsodi, Claudia P. Figueiredo, Emanuelle V. de Lima, Emily A. Dickie, Wenbin Wei, Robson Coutinho-Silva, Andy Merritt, Terry K. Smith, Michael P. Barrett, Bartira Rossi-Bergmann, Paul W. Denny and Patrick G. Steel

ACS Infect. Dis., 2021, 7, 47
DOI: 10.1021/acsinfecdis.0c00546

In vitro evaluation and in vivo efficacy of nitroimidazole-sulfanyl ethyl derivatives against Leishmania (V.) braziliensis and Leishmania (L.) mexicana

Zuleima Blanco, Michael R. Mijares, Hegira Ramírez, Esteban Fernandez-Moreira, Henry J. Oviedo, Noris M. Rodríguez and Jaime E. Charris

Parasitol Res, 2021, 120, 3307
DOI: 10.1007/s00436-021-07266-w

Arylthiosemicarbazones as antileishmanial agents

José Ignacio Manzano, Florent Cochet, Benjamin Boucherle, Verónica Gómez-Pérez, Ahcène Boumendjel, Francisco Gamarro and Marine Peuchmaur

European Journal of Medicinal Chemistry, 2016, 123, 161
DOI: 10.1016/j.ejmech.2016.07.014

ChemInform Abstract: Antileishmanial Drug Discovery: Comprehensive Review of the Last 10 Years

Jaiprakash N. Sangshetti, Firoz A. Kalam Khan, Abhishek A. Kulkarni, Rohidas Arote and Rajendra H. Patil

ChemInform, 2015, 46
DOI: 10.1002/chin.201528303

Synthesis, antileishmanial activity and cytotoxicity of 2,3-diaryl- and 2,3,8-trisubstituted imidazo[1,2-a]pyrazines

Pascal Marchand, Marc-Antoine Bazin, Fabrice Pagniez, Guillaume Rivière, Lizeth Bodero, Sophie Marhadour, Marie-Renée Nourrisson, Carine Picot, Sandrine Ruchaud, Stéphane Bach, Blandine Baratte, Michel Sauvain, Denis Castillo Pareja, Abraham J. Vaisberg and Patrice Le Pape

European Journal of Medicinal Chemistry, 2015, 103, 381
DOI: 10.1016/j.ejmech.2015.09.002

Potential Triazole-based Molecules for the Treatment of Neglected Diseases

Susimaire Pedersoli Mantoani, Peterson de Andrade, Talita Perez Cantuaria Chierrito, Andreza Silva Figueredo and Ivone Carvalho

CMC, 2019, 26, 4403
DOI: 10.2174/0929867324666170727103901

Topical Bambusa vulgaris Extract Enhances Wound Healing in Cutaneous Leishmaniasis

Zahra Ghanbarinasab, Mahnaz Hosseini-Bensenjan, Elaheh Ziaei Ziabari, Shiva Aminnia, Roham Borazjani, Mohammad Rastegarian Jahromi, Qasem Asgari, Bahador Sarkari, Soheil Ashkani-Esfahani and Mario M. D’Elios

Journal of Pathogens, 2021, 2021, 1
DOI: 10.1155/2021/7860474

Hive Products: Composition, Pharmacological Properties, and Therapeutic Applications

Roberto Bava, Fabio Castagna, Carmine Lupia, Giusi Poerio, Giovanna Liguori, Renato Lombardi, Maria Diana Naturale, Rosa Maria Bulotta, Vito Biondi, Annamaria Passantino, Domenico Britti, Giancarlo Statti and Ernesto Palma

Pharmaceuticals, 2024, 17, 646
DOI: 10.3390/ph17050646

Urea‐Promoted Neat Synthesis of Fused Dihydroisoquinolines and Disubstituted Pyridines: A Mechanistic Observation with Molecular‐Sensing Studies

Sk Abulkalam Azad, Anirban Bera, Jayanta Samanta, Nayim Sepay, Rathin Jana, Chandan Kumar Pal, Mijanur Rahaman Molla, Debabrata Maiti and Shubhankar Samanta

Chemistry A European J, 2024, 30
DOI: 10.1002/chem.202303287

Physalis angulata Linn. as a medicinal plant (Review)

Ariyani Novitasari, Enny Rohmawaty and Aziiz Rosdianto

Biomed Rep, 2024, 20
DOI: 10.3892/br.2024.1735

Novel prenyloxy chalcones as potential leishmanicidal and trypanocidal agents: Design, synthesis and evaluation

José C. Espinoza-Hicks, Karla Fabiola Chacón-Vargas, Jessica L. Hernández-Rivera, Benjamín Nogueda-Torres, Joaquín Tamariz, Luvia Enid Sánchez-Torres and Alejandro Camacho-Dávila

European Journal of Medicinal Chemistry, 2019, 167, 402
DOI: 10.1016/j.ejmech.2019.02.028

First example of peptides targeting the dimer interface of Leishmania infantum trypanothione reductase with potent in vitro antileishmanial activity #

Marta Ruiz-Santaquiteria, Pedro A. Sánchez-Murcia, Miguel A. Toro, Héctor de Lucio, Kilian Jesús Gutiérrez, Sonia de Castro, Filipa A.C. Carneiro, Federico Gago, Antonio Jiménez-Ruiz, María-José Camarasa and Sonsoles Velázquez

European Journal of Medicinal Chemistry, 2017, 135, 49
DOI: 10.1016/j.ejmech.2017.04.020

Synthesis and Evaluation of (Bis)benzyltetrahydroisoquinoline Alkaloids as Antiparasitic Agents

Ana Sozanschi, Hannah Asiki, Maiara Amaral, Erica V. de Castro Levatti, Andre G. Tempone, Richard J. Wheeler and Edward A. Anderson

JACS Au, 2024, 4, 847
DOI: 10.1021/jacsau.4c00007

Challenges and Opportunities for Drug Discovery in Developing Countries: The Example of Cutaneous Leishmaniasis

Abdrrahman S. Surur, Abebaw Fekadu, Eyasu Makonnen and Asrat Hailu

ACS Med. Chem. Lett., 2020, 11, 2058
DOI: 10.1021/acsmedchemlett.0c00446

Substituted 1,5-naphthyridine derivatives as novel antileishmanial agents. Synthesis and biological evaluation

Ana Tejería, Yolanda Pérez-Pertejo, Rosa M. Reguera, Rafael Balaña-Fouce, Concepción Alonso, María González, Gloria Rubiales and Francisco Palacios

European Journal of Medicinal Chemistry, 2018, 152, 137
DOI: 10.1016/j.ejmech.2018.04.033

Synthesis and in vitro evaluation of substituted tetrahydroquinoline-isoxazole hybrids as anticancer agents

Fausto M. Güiza, Yenny Bueno Duarte, Stelia C. Mendez-Sanchez and Arnold R. Romero Bohórquez

Med Chem Res, 2019, 28, 1182
DOI: 10.1007/s00044-019-02363-z

Synthesis, bio-physical and anti-leishmanial studies of some novel indolo[3,2-a]phenanthridine derivatives

Jeet Banerjee, Anindita Bhattacharjee, Arunima Biswas and Shital K. Chattopadhyay

Bioorganic Chemistry, 2022, 123, 105766
DOI: 10.1016/j.bioorg.2022.105766

Advancement in leishmaniasis diagnosis and therapeutics: An update

Diksha Kumari, Summaya Perveen, Rashmi Sharma and Kuljit Singh

European Journal of Pharmacology, 2021, 910, 174436
DOI: 10.1016/j.ejphar.2021.174436

Antiparasitic activity and cytotoxic potential of the hydroethanolic extract the leaves of Tocoyena formosa

Francisco Rafael Alves Santana Cesário, Thaís Rodrigues de Albuquerque, Giovana Mendes de Lacerda, Maria Neyze Martins Fernandes, Maria Rayane Correia de Oliveira, Anita Oliveira Brito Pereira Bezerr Martins, Miriam Rolón, Maria Celeste Vega Gomez, Antonieta Rojas de Arias, Henrique Douglas Melo Coutinho, Marta Regina Kerntopf and Irwin Rose Alencar de Menezes

Vegetos, 2024, 38, 1261
DOI: 10.1007/s42535-024-00948-7

Exploring the ability of dihydropyrimidine-5-carboxamide and 5-benzyl-2,4-diaminopyrimidine-based analogues for the selective inhibition of L. major dihydrofolate reductase

Maria Bibi, Naveeda Akhter Qureshi, Abdul Sadiq, Umar Farooq, Abbas Hassan, Nargis Shaheen, Irfa Asghar, Duaa Umer, Azmat Ullah, Farhan A. Khan, Muhammad Salman, Ahtaram Bibi and Umer Rashid

European Journal of Medicinal Chemistry, 2021, 210, 112986
DOI: 10.1016/j.ejmech.2020.112986

Structure based medicinal chemistry-driven strategy to design substituted dihydropyrimidines as potential antileishmanial agents

Umer Rashid, Riffat Sultana, Nargis Shaheen, Syed Fahad Hassan, Farhana Yaqoob, Muhammad Jawad Ahmad, Fatima Iftikhar, Nighat Sultana, Saba Asghar, Masoom Yasinzai, Farzana Latif Ansari and Naveeda Akhter Qureshi

European Journal of Medicinal Chemistry, 2016, 115, 230
DOI: 10.1016/j.ejmech.2016.03.022

Eugenol derived immunomodulatory molecules against visceral leishmaniasis

Mamilla R. Charan Raja, Anand Babu Velappan, Davidraj Chellappan, Joy Debnath and Santanu Kar Mahapatra

European Journal of Medicinal Chemistry, 2017, 139, 503
DOI: 10.1016/j.ejmech.2017.08.030

American tegumentary leishmaniasis in Brazil: a critical review of the current therapeutic approach with systemic meglumine antimoniate and short‐term possibilities for an alternative treatment

Sílvia H. Carvalho, Frédéric Frézard, Neila P. Pereira, Alexandre S. Moura, Lucinéia M. Q. C. Ramos, Gabriel B. Carvalho and Manoel O. C. Rocha

Tropical Med Int Health, 2019, 24, 380
DOI: 10.1111/tmi.13210

Integrating traditional QSAR and read-across-based regression models for predicting potential anti-leishmanial azole compounds

Rajat Nandi, Anupama Sharma, Ananya Priya and Diwakar Kumar

Mol Divers, 2025, 29, 3207
DOI: 10.1007/s11030-024-11070-w

2-(Bipiperidin-1-yl)-5-(nitroaryl)-1,3,4-thiadiazoles: Synthesis, evaluation of in vitro leishmanicidal activity, and mechanism of action

Zahra Mojallal-Tabatabaei, Parham Foroumadi, Mahsa Toolabi, Fereshteh Goli, Setareh Moghimi, Sussan Kaboudanian-Ardestani and Alireza Foroumadi

Bioorganic & Medicinal Chemistry, 2019, 27, 3682
DOI: 10.1016/j.bmc.2019.07.009

Comprehensive Insights Into Sulfanilamido‐Based Medicinal Design and Research

Yi‐Xin Wang, Juan Wang, Lin‐Li Mou, Hui‐Zhen Zhang, Guang‐Ying Chen and Cheng‐He Zhou

Medicinal Research Reviews, 2025
DOI: 10.1002/med.22115

In vitro and in silico exploration of newly synthesized triazolyl- isonicotinohydrazides as potent antitubercular agents

Rajubai D. Bakale, Pramod S. Phatak, Sanket S. Rathod, Prafulla B. Choudhari, Estharla Madhu Rekha, Dharmarajan Sriram, Ravibhushan S. Kulkarni and Kishan P. Haval

Journal of Biomolecular Structure and Dynamics, 2025, 43, 1372
DOI: 10.1080/07391102.2023.2291826

In vitro anti-Leishmania activity and molecular docking of spiro-acridine compounds as potential multitarget agents against Leishmania infantum

Fernanda S. Almeida, Gleyton L.S. Sousa, Juliana C. Rocha, Frederico F. Ribeiro, Márcia Rosa de Oliveira, Teresa Cristina Soares de Lima Grisi, Demetrius A.M. Araújo, Michelangela S. de C. Nobre, Rosane N. Castro, Ian P.G. Amaral, Tatjana S.L. Keesen and Ricardo Olímpio de Moura

Bioorganic & Medicinal Chemistry Letters, 2021, 49, 128289
DOI: 10.1016/j.bmcl.2021.128289

Recent trends in the design of antimicrobial agents using Ugi-multicomponent reaction

Mukesh Tandi and Sandeep Sundriyal

Journal of the Indian Chemical Society, 2021, 98, 100106
DOI: 10.1016/j.jics.2021.100106

Quinolizidine-Derived Lucanthone and Amitriptyline Analogues Endowed with Potent Antileishmanial Activity

Michele Tonelli, Anna Sparatore, Nicoletta Basilico, Loredana Cavicchini, Silvia Parapini, Bruno Tasso, Erik Laurini, Sabrina Pricl, Vito Boido and Fabio Sparatore

Pharmaceuticals, 2020, 13, 339
DOI: 10.3390/ph13110339

Synthesis, Antileishmanial Activity and Molecular Docking Study of a Series of Dihydropyridine Derivatives

Ali-Reza Rezaei, Sedigheh Saberi and Saghi Sepehri

Polycyclic Aromatic Compounds, 2023, 43, 4640
DOI: 10.1080/10406638.2022.2092877

Systematic search for benzimidazole compounds and derivatives with antileishmanial effects

Juan Carlos Sánchez-Salgado, Pablo Bilbao-Ramos, María Auxiliadora Dea-Ayuela, Francisco Hernández-Luis, Francisco Bolás-Fernández, José L. Medina-Franco and Yareli Rojas-Aguirre

Mol Divers, 2018, 22, 779
DOI: 10.1007/s11030-018-9830-7

Amino-Substituted 3-Aryl- and 3-Heteroarylquinolines as Potential Antileishmanial Agents

Jared T. Hammill, Vitaliy M. Sviripa, Liliia M. Kril, Diana Ortiz, Corinne M. Fargo, Ho Shin Kim, Yizhe Chen, Jonah Rector, Amy L. Rice, Malgorzata A. Domagalska, Kristin L. Begley, Chunming Liu, Vivek M. Rangnekar, Jean-Claude Dujardin, David S. Watt, Scott M. Landfear and R. Kiplin Guy

J. Med. Chem., 2021, 64, 12152
DOI: 10.1021/acs.jmedchem.1c00813

Design, synthesis, antileishmanial, and antifungal biological evaluation of novel 3,5‐disubstituted isoxazole compounds based on 5‐nitrofuran scaffolds

Ozildéia S. Trefzger, Natália V. Barbosa, Renata L. Scapolatempo, Amarith R. das Neves, Maria L. F. S. Ortale, Diego B. Carvalho, Antônio M. Honorato, Mariana R. Fragoso, Cristiane Y. K. Shuiguemoto, Renata T. Perdomo, Maria F. C. Matos, Marilene R. Chang, Carla C. P. Arruda and Adriano C. M. Baroni

Archiv der Pharmazie, 2020, 353
DOI: 10.1002/ardp.201900241

First‐in‐class pyrido[2,3‐d]pyrimidine‐2,4(1H,3H)‐diones against leishmaniasis and tuberculosis: Rationale, in vitro, ex vivo studies and mechanistic insights

Deepthi Ramesh, Deblina Sarkar, Annu Joji, Monica Singh, Amaresh K. Mohanty, Balaji G. Vijayakumar, Mitali Chatterjee, Dharmarajan Sriram, Suresh K. Muthuvel and Tharanikkarasu Kannan

Archiv der Pharmazie, 2022, 355
DOI: 10.1002/ardp.202100440

Green synthesis, in vitro , and in silico assessments of hydrazone-Schiff bases as potential antileishmanial agents

Sadia Khan, Sher Wali Khan, Momin Khan, Saira Nayab, Muhammad Naveed Umar, Syed Wadood Ali Shah and Haroon Ur Rashid

Future Medicinal Chemistry, 2025, 17, 1641
DOI: 10.1080/17568919.2025.2533114

Recent Advances in the Discovery of Novel Antiprotozoal Agents

Seong-Min Lee, Min-Sun Kim, Faisal Hayat and Dongyun Shin

Molecules, 2019, 24, 3886
DOI: 10.3390/molecules24213886

A Critical Review on Recent Heterocyclics Identified for Anti-Leishmanial Therapy

Swati Rathore, Adarsh Sahu, Ram Kishore Agrawal and Asmita Gajbhiye Patil

CCB, 2022, 16, 81
DOI: 10.2174/2212796816666220328130800

NaBH4‐Induced Chemoselective Mechanochemical Neat Synthesis of Bio‐Active Dihydrofuran/ϵ‐Hydroxy‐α,β‐Unsaturated Esters and Synthetic Application to Isoindoles

Paritosh Barik, Chandan Kumar Pal, Sudipta Chakraborty, Sk Abulkalam Azad, Prasanta Patra, Rathin Jana, Mijanur Rahaman Molla and Shubhankar Samanta

Eur J Org Chem, 2024
DOI: 10.1002/ejoc.202400534

Therapeutic Potential of Marine-Derived Cyclic Peptides as Antiparasitic Agents

Ricardo Ribeiro, Lia Costa, Eugénia Pinto, Emília Sousa and Carla Fernandes

Marine Drugs, 2023, 21, 609
DOI: 10.3390/md21120609

A Novel Automated Framework for QSAR Modeling of Highly Imbalanced Leishmania High-Throughput Screening Data

Omar Casanova-Alvarez, Aliuska Morales-Helguera, Miguel Ángel Cabrera-Pérez, Reinaldo Molina-Ruiz and Christophe Molina

J. Chem. Inf. Model., 2021, 61, 3213
DOI: 10.1021/acs.jcim.0c01439

Antileishmanial evaluation of clubbed bis(indolyl)-pyridine derivatives: One-pot synthesis, in vitro biological evaluations and in silico ADME prediction

Firoz A. Kalam Khan, Zahid Zaheer, Jaiprakash N. Sangshetti, Rajendra H. Patil and Mazahar Farooqui

Bioorganic & Medicinal Chemistry Letters, 2017, 27, 567
DOI: 10.1016/j.bmcl.2016.12.018

Susceptibility of Leishmania to novel pentavalent organometallics: Investigating impact on DNA and membrane integrity in antimony(III)‐sensitive and ‐resistant strains

Arshad Islam, Bruno Rodrigues do Prado, Dalton Dittz, Bernardo Lages Rodrigues, Sydnei Magno da Silva, Rubens L. do Monte‐Neto, Muhammad Shabeer, Frédéric Frézard and Cynthia Demicheli

Drug Development Research, 2024, 85
DOI: 10.1002/ddr.22194

Curcumin-loaded nanostructured systems for treatment of leishmaniasis: a review

Douglas Dourado, Thayse Silva Medeiros, Éverton do Nascimento Alencar, Edijane Matos Sales and Fábio Rocha Formiga

Beilstein J. Nanotechnol., 2024, 15, 37
DOI: 10.3762/bjnano.15.4

Drug repositioning to discover novel ornithine decarboxylase inhibitors against visceral leishmaniasis

Sabahat Yasmeen Sheikh, Waseem Ahmad Ansari, Firoj Hassan, Tabrez Faruqui, Mohammad Faheem Khan, Yusuf Akhter, Abdul Rahman Khan, Maqsood A. Siddiqui, Abdulaziz A. Al‐Khedhairy and Malik Nasibullah

J of Molecular Recognition, 2023, 36
DOI: 10.1002/jmr.3021

Synthesis of N-substituted indole derivatives as potential antimicrobial and antileishmanial agents

Shweta Tiwari, Seema Kirar, Uttam Chand Banerjee, Kishore Babu Neerupudi, Sushma Singh, Aabid Abdullah Wani, Prasad V. Bharatam and Inder Pal Singh

Bioorganic Chemistry, 2020, 99, 103787
DOI: 10.1016/j.bioorg.2020.103787

Synthesis and leishmanicidal evaluation of sulfanyl‐ and sulfonyl‐tethered functionalized benzoate derivatives featuring a nitroimidazole moiety

Miguel Rodríguez, Joyce Gutiérrez, José Domínguez, Philippe A. Peixoto, Alexis Fernández, Noris Rodríguez, Denis Deffieux, Luis Rojas, Stéphane Quideau, Laurent Pouységu and Jaime Charris

Archiv der Pharmazie, 2020, 353
DOI: 10.1002/ardp.202000002

Ensemble‐based ADME–Tox profiling and virtual screening for the discovery of new inhibitors of the Leishmania mexicana cysteine protease CPB2.8ΔCTE

Angela Scala, Antonio Rescifina, Nicola Micale, Anna Piperno, Tanja Schirmeister, Louis Maes and Giovanni Grassi

Chem Biol Drug Des, 2018, 91, 597
DOI: 10.1111/cbdd.13124

Antiparasitic Behavior of Trifluoromethylated Pyrazole 2-Amino-1,3,4-thiadiazole Hybrids and Their Analogues: Synthesis and Structure-Activity Relationship

Jeniffer do Nascimento Ascencio Camargo, Karlos Eduardo Pianoski, Mariellen Guilherme dos Santos, Danielle Lazarin-Bidóia, Hélito Volpato, Sidnei Moura, Celso Vataru Nakamura and Fernanda Andreia Rosa

Front. Pharmacol., 2020, 11
DOI: 10.3389/fphar.2020.591570

Anticancer, antimicrobial and antioxidant potential of sterically tuned bis-N-heterocyclic salts

Noor ul Huda, Shamsul Islam, Muhammad Zia, Kainaat William, Fakhar i Abbas, Muhammad Ihtisham Umar, Muhammad Adnan Iqbal and Abdul Mannan

Zeitschrift für Naturforschung C, 2018, 74, 17
DOI: 10.1515/znc-2018-0095

Individual and combined antiparasitic effect of six plant metabolites against Leishmania amazonensis and Trypanosoma cruzi

Louis P. Sandjo, Milene H. de Moraes, Victor Kuete, Blaise C. Kamdoum, Bonaventure T. Ngadjui and Mario Steindel

Bioorganic & Medicinal Chemistry Letters, 2016, 26, 1772
DOI: 10.1016/j.bmcl.2016.02.044

Synthesis of diverse (E)‐2‐((1H‐imidazol‐1‐yl)methyl)‐2‐((benzyloxy)methyl)‐2,3‐dihydro‐1H‐inden‐1‐one O‐benzyl oxime derivatives as potent antileishmanial agents

Santosh M. Surwase, Yogesh D. Mane, Mahesh M. Surwase and Bhimrao C. Khade

Journal of Heterocyclic Chem, 2020, 57, 724
DOI: 10.1002/jhet.3812

A review on potential therapeutic targets for the treatment of leishmaniasis

Sabahat Yasmeen Sheikh, Firoj Hassan, Deepanjali Shukla, Shashi Bala, Tabrez Faruqui, Yusuf Akhter, Abdul Rahman Khan and Malik Nasibullah

Parasitology International, 2024, 100, 102863
DOI: 10.1016/j.parint.2024.102863

Open Synthesis Network Research in an Undergraduate Laboratory: Development of Benzoxazole Amide Derivatives against Leishmania Parasite

Scott C. Faville, Kes Harris-Hamdscomb, Owain Harker, Stephanie Mattison, Hajie Tamorite, Joshua Bristowe, Daniel Daly, Raissa Ege, Haoyuan He, Julian Jones, Abby McCorkindale, Kerry Mei, Ashleigh Monson, Lana Moree, Finley Perkovic, Georgia Rickerby, Jack Robinson, Felix Rudkin, Luke Whibley, Rebecca Worthington, Courtney Ennis, Sara de la Harpe, Thomasin Brind, Andrew Hopkins, Kaleb Winefield, Sarah Hendrickx, Guy Caljon, Benjamin Perry and Andrea J. Vernall

J. Chem. Educ., 2022, 99, 1682
DOI: 10.1021/acs.jchemed.1c01213

Amino acid ionic liquid-catalyzed synthesis, anti-Leishmania activity, molecular docking, molecular dynamic simulation, and ADME study of 3,4-dihydropyrimidin-2(1H)-(thio)ones

Nitin Rode, Aafaq Tantray, Amruta Shelar, Rajendra Patil and Santosh Terdale

Synthetic Communications, 2022, 52, 190
DOI: 10.1080/00397911.2021.2010757

Dual-target drugs against Leishmania donovani for potential novel therapeutics

Kushal Bora, Manash Sarma, Shankar Prasad Kanaujia and Vikash Kumar Dubey

Sci Rep, 2023, 13
DOI: 10.1038/s41598-023-45448-x

Exploring hydrophilic 2,2-di(indol-3-yl)ethanamine derivatives against Leishmania infantum

Alessia Centanni, Aurora Diotallevi, Gloria Buffi, Diego Olivieri, Nuno Santarém, Antti Lehtinen, Jari Yli-Kauhaluoma, Anabela Cordeiro-da-Silva, Paula Kiuru, Simone Lucarini, Luca Galluzzi and Nisha Singh

PLoS ONE, 2024, 19, e0301901
DOI: 10.1371/journal.pone.0301901

Design, synthesis and antitrypanosomatid activities of 3,5‐diaryl‐isoxazole analogues based on neolignans veraguensin, grandisin and machilin G

Ozildéia S. Trefzger, Amarith R. das Neves, Natália V. Barbosa, Diego B. Carvalho, Indiara C. Pereira, Renata T. Perdomo, Maria F. C. Matos, Nidia C. Yoshida, Massuo J. Kato, Sérgio de Albuquerque, Carla C. P. Arruda and Adriano C. M. Baroni

Chem Biol Drug Des, 2019, 93, 313
DOI: 10.1111/cbdd.13417

Synthesis and antileishmanial activity of fluorinated rhodacyanine analogues: The ‘fluorine-walk’ analysis

Thitiya Lasing, Atchara Phumee, Padet Siriyasatien, Kantima Chitchak, Parichatr Vanalabhpatana, Kit-Kay Mak, Chew Hee Ng, Tirayut Vilaivan and Tanatorn Khotavivattana

Bioorganic & Medicinal Chemistry, 2020, 28, 115187
DOI: 10.1016/j.bmc.2019.115187

Design, synthesis and evaluation of novel carboline-triazole hybrids as promising antimalarial agents

Ajay Kishor kushawaha, Rohini Nandi, Arvind Kumar Jaiswal, Hemlata Bhatt, Sarita Katiyar, Alisha Ansari, Abhijit Deb Choudhury, Shabeer Ali, Shikha Mishra, Rabi Sankar Bhatta, Mrigank Srivastava, Satish Mishra and Koneni V. Sashidhara

European Journal of Medicinal Chemistry, 2025, 290, 117514
DOI: 10.1016/j.ejmech.2025.117514